Modulation of sleep/wake patterns by gephyrin phosphorylation status
European Journal of Neuroscience · 2024
DOI: 10.1111/ejn.16464 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neuroscience, 2024. Verfasst von Yuan-Chen Tsai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Sleep, Membrane Proteins, Wakefulness, Receptors, GABA-A. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UZH Forschungskredit Can-doc, Olga Mayenfisch Foundation, University of Zurich.
Abstract (Originalsprache)
Sleep/wake cycles intricately shape physiological activities including cognitive brain functions, yet the precise molecular orchestrators of sleep remain elusive. Notably, the clinical impact of benzodiazepine drugs underscores the pivotal role of GABAergic neurotransmission in sleep regulation. However, the specific contributions of distinct GABA A receptor subtypes and their principal scaffolding protein, gephyrin, in sleep dynamics remain unclear. The evolving role of synaptic phospho‐proteome alterations at excitatory and inhibitory synapses suggests a potential avenue for modulating gephyrin and, consequently, GABA A Rs for sleep through on‐demand kinase recruitment. Our study unveils the distinctive roles of two prevalent GABA A receptor subtypes, α1‐ and α2‐GABA A Rs, in influencing sleep duration and electrical sleep activity. Notably, the absence of α1‐GABA A Rs emerges as central in sleep regulation, manifesting significant alterations in both non‐rapid eye movement (NREM) and rapid eye movement (REM) sleep during dark or active phases, accompanied by altered electroencephalogram (EEG) patterns across various frequencies. Gephyrin proteomics analysis reveals sleep/wake‐dependent interactions with a repertoire of known and novel kinases. Crucially, we identify the regulation of gephyrin interaction with ERK1/2, and phosphorylations at serines 268 and 270 are dictated by sleep/wake cycles. Employing AAV‐eGFP‐gephyrin or its phospho‐null variant (S268A/S270A), we disrupt sleep either globally or locally to demonstrate gephyrin phosphorylation as a sleep regulator. In summary, our findings support the local cortical sleep hypothesis and we unveil a molecular mechanism operating at GABAergic synapses, providing critical insights into the intricate regulation of sleep.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
- Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
ORCID-Profile: Shiva K Tyagarajan
Förderung
- UZH Forschungskredit Can-doc
- Olga Mayenfisch Foundation
- University of Zurich
- Swiss National Science Foundation
- Olga Mayenfisch Stiftung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Zürich
Zitieren
APA
Tsai, Y. C., ElGrawani, W., Muheim, C., Spinnler, A., Campbell, B. F. N., Lasic, D., Hleihil, M., Brown, S. A., & Tyagarajan, S. K. (2024). Modulation of sleep/wake patterns by gephyrin phosphorylation status. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16464
Vancouver
Tsai YC, ElGrawani W, Muheim C, Spinnler A, Campbell BFN, Lasic D, et al. Modulation of sleep/wake patterns by gephyrin phosphorylation status. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16464
BibTeX
@article{Tsai2024,
author = {Tsai, Yuan-Chen and ElGrawani, Waleed and Muheim, Christine and Spinnler, Andrea and Campbell, Benjamin F N and Lasic, Denis and Hleihil, Mohammad and Brown, Steven A and Tyagarajan, Shiva K},
title = {Modulation of sleep/wake patterns by gephyrin phosphorylation status},
journal = {European Journal of Neuroscience},
year = {2024},
doi = {10.1111/ejn.16464}
}
EUVIMED